𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic significance of autoimmunity during treatment of melanoma with interferon

✍ Scribed by Michal T. Krauze; Ahmad Tarhini; Helen Gogas; John M. Kirkwood

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
140 KB
Volume
33
Category
Article
ISSN
1863-2297

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b
✍ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis

Evolving significance of prognostic mark
Evolving significance of prognostic markers associated with treatment improvement in patients with Stage 4 neuroblastoma
✍ Jaume Mora; William L. Gerald; Jing Qin; Nai-Kong V. Cheung πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

## Abstract ## BACKGROUND With recent improvements in the treatment and outcome of patients with neuroblastoma (NB), the authors reassessed the prognostic importance of clinical and biologic markers in patients with Stage 4 NB who were treated at the Memorial Sloan‐Kettering Cancer Center (MSKCC).